#drug-innovation

[ follow ]
#chronic-kidney-disease-treatment #glp-1-receptor-agonists #combination-therapy #sglt2-inhibitors
Medicine
fromwww.scientificamerican.com
6 days ago

Drugs like Ozempic are improving kidney treatment and changing lives

GLP-1 receptor agonists, finerenone, and SGLT2 inhibitors represent breakthrough treatments for chronic kidney disease, with combined therapy potentially adding decades to patients' lives.
Healthcare
fromFortune
4 months ago

Novo Nordisk wants to keep its crown leading the weight loss drugs pack-despite outlook downgrades and lawsuits, its CFO has a plan | Fortune

Novo Nordisk faces declining sales and stock after GLP-1 competition; success depends on launching new products like Wegovy pill, CagriSema, and amycretin.
[ Load more ]